Updated:
Mint12 Pharma
Mint12 Pharma is a Florida-based family office investing directly in pharmaceutical and healthcare opportunities.
Mint12 Pharma
Mint12 Pharma operates as a family office with a sector-specific focus on pharmaceuticals and healthcare, headquartered in Orlando, Florida, with an additional office in Gainesville. The firm's founding year and the identity of its founding principal have not been publicly disclosed, and the precise origin of the wealth underlying the office remains opaque. The firm's investment strategy centers on direct investments and co-investments in the pharmaceutical value chain, including drug development, specialty pharma, and healthcare services. Mint12 Pharma likely targets both early-stage and growth-stage opportunities, given the diverse stages common in such a focused mandate. The geographic footprint appears concentrated in North America, with a particular emphasis on Florida's life-science corridor. No public data is available on the firm's total deployment, team size, or professional staff. The firm does not publicly list any portfolio companies, funds, or philanthropic vehicles. As of mid-2026, there are no verifiable recent operational events in the public domain to inform current posture. A structural differentiator, if any, remains unconfirmed. The firm's existence and narrow sector focus distinguish it from more diversified family offices, but verification of sourcing model, governance, or succession structure is not possible from public records.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
US
City
Orlando
Corporate office
Orlando, FL, United States
Additional offices
Gainesville, FL, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Mint12 Pharma?
The firm does not publicly disclose the names or roles of its investment professionals. No principals are listed on the firm's limited public profile, and no external sources name specific operators at Mint12 Pharma.
Does Mint12 Pharma participate in fund commitments or only direct deals?
Based on the firm's name and sector focus, Mint12 Pharma appears oriented toward direct investments and co-investments in pharma and healthcare companies. There is no public evidence of fund-of-funds or secondary commitments.
What investment stages does Mint12 Pharma typically target?
Without public disclosure, the target stage is inferred from the firm's pharma focus: likely early-stage drug development through growth-stage specialty pharma. The firm's dual-office presence in Orlando and Gainesville, a noted life-science hub, supports this inference.
Which sectors does Mint12 Pharma explicitly avoid?
The firm's name suggests a strict focus on pharma, implying avoidance of unrelated sectors like tech, real estate, or consumer goods. No explicit negative sector statements are on the public record.
How is Mint12 Pharma structured as a family office?
The firm operates as a family office, but its exact structure—whether single-family or multi-family—is not publicly known. It maintains offices in Orlando and Gainesville, Florida.
Where does the underlying wealth of Mint12 Pharma come from?
The source of the family wealth has not been publicly disclosed. The firm's name suggests a pharma or healthcare industry origin, but no confirming evidence is available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: